Dr. Mona, Chiu Lai Shan, 趙麗珊 Specialist in Dermatology and Venereology

Slides:



Advertisements
Similar presentations
Hospital-acquired and community-acquired MRSA in hospitals
Advertisements

Methicillin resistant Staphylococcus aureus (MRSA) in the Nordic countries Petter Elstrøm Advisor Norwegian Institute of Public Health.
MRSA Community Acquired Methicillin Resistant Staphylococcus Aureus
MRSA: Epidemiology & Treatment. MRSA: Epidemiology & Treatment: Points of this Talk - MRSA is primarily healthcare-associated - Community-acquired MRSA.
MRSA Update 2013 David K. Hong, MD Pediatrics/Infectious Diseases &
MRSA.
Methicillin Resistant Staphylococcus aureus (MRSA) in the Community: Epidemiology and Management Rachel Gorwitz, MD, MPH Division of Healthcare Quality.
Hot Topics in Pediatric ID Robert J. Leggiadro, MD Chairman Department of Pediatrics Lincoln Medical Center Professor of Clinical Pediatrics Weill Medical.
Methicillin-resistant staphylococcus aureus By Jackson Cullop
Lecture 3 MRSA Methicillin resistant S. aureus
Gram Positive Cocci: STAPHYLOCOCCUS EDWARD-BENGIE L. MAGSOMBOL, MD, FPCP, FPCC Department of Microbiology Fatima College of Medicine.
1 Skilled Nursing, Inc. Staffing & Search MRSA Methicillin Resistant Staph Aureus HA MRSA and CA MRSA Causes SSTI’s, sepsis, necrotizing fascitis and fatality.
Action-Oriented Guidance for Community-Based Prevention
MRSA Barbara Kilian, MD St.Luke’s Roosevelt Academic Associate Program Fall 2005.
The Ugly face of MRSA (Methicillin Resistant Staphylococcus aureus) MRSA is a staph aureus infection that has become resistant to the class of antibiotics,
Batterjee Medical College. Dr. Manal El Said Head of Microbiology Department Staphylococci Staphylococcus aureus.
Outpatient management of skin and soft tissue infections, specifically for community-associated MRSA Patient presents with signs/ symptoms of skin infection:
A SECOND LOOK AT HOW TO COMBAT THIS THREAT JOHN WOODCOX RN CRRN.
Information on Staphlococcus aureus and Resistant Staphlococcus aureus (MRSA) Prepared by: Kathryn Billings.
©2008, Promega Corporation. All rights reserved. Emerging Pathogens Community-Associated Methicillin- Resistant Staphylococcus aureus.
Community- Associated MRSA Maha Assi, MD, MPH. MRSA Hits the Media October 16, 2007 October 16, 2007 Lead story on MRSA Lead story on MRSA “superbug killing.
Methicillin-Resistant Staphylococcus aureus (MRSA)
MRSA and the Cook County Jail: Analysis of Isolates That May Be From a Reservoir of Community- Associated Infections Lena Kuo, MD, Robert Daum, MD, Susan.
MRSA in Corrections Danae Bixler, MD, MPH
MRSA and VRE in a Rural Community Hospital Graduation Project 2008 Mehvish Ally.
Navpreet Sahsi.  Major pathogen of skin and soft tissue  Major nosocomial flora  Penicillin resistance in 1940’s  Methicillin resistance in 1960’s.
Staphylococcal Bacteremia and Endocarditis: Epidemiological Considerations March 6, 2006 John Edwards, Jr., M.D Professor of Medicine UCLA School of Medicine.
COMMUNITY ACQUIRED MRSA Pisespong Patamasucon, M.D. Pediatric Infectious Diseases UNSOM - Las Vegas.
MRSA in Correctional Facilities Michael Kelley, M.D., M.P.H. Director of Preventive Medicine Texas Department of Criminal Justice.
Lilly Immergluck, MD Associate Professor of Pediatrics
The Super Bug? Alexander L. Brzezny, MD, MPH Health Officer Grant County Health District September 4 th, 2007.
Methicillin Resistant Staphylococcus aureus Catherine D. Bacheller, MD Infectious Diseases Medical Director, Infection Prevention and Control KMC Assistant.
Medical Microbiology Chapter 22 Staphylococcus and Related Organisms.
Antibiotics Tamar Barlam Infectious Disease Director, Antimicrobial Stewardship.
MRSA in Our Community Tony Chang, MD Primary Care Case Conference August 2, 2006.
Furuncles/Carbuncles
Community Acquired MRSA CA-MRSA Margaret Teitelbaum School Nurse/Health Educator Westfield High School.
Community-acquired methicillin-resistant Staph. aureus (CA-MRSA): Amarillo experience Infectious Disease Epidemiology Work Group Texas Department of State.
Evidence-based Medicine. Case Presentation 27 yo AA male presents to clinic with 3 days of pain and swelling in right leg First noted several spider bites.
Community-Associated Methicillin-Resistant Staphylococcus aureus Ruth Lynfield, M.D. Minnesota Department of Health.
Panton-Valentine Leukocidin (PVL) is a toxin that destroys white blood cells and is a virulence factor in some strains of Staphylococcus aureus. PVL occurs.
Staphylococcus Dr Julian Ng. General About 40 known Staphylococcus spp. Gram Stain: Gram positive coccus; 0.5µm- 1.5µm usu. arranged in grape-like clusters.
The Carriage of Staphylococcus aureus And The Prevalence of Virulence Genes In College Students Sachiya Ridore Mentor: Dr. Gray, Department of Biology,
Understanding Methicillin-Resistant Staphylococcus aureus
Methicillin-Resistant Staphylococcus Aureus (MRSA)
Cheryl Meddles-Torres, DNP, RN, FNP-C Shuang Hu
ANTIBIOTIC RESISTANCE & CA-MRSA Present by Manita Attasuriyanan, MD.
A Clinician’s Approach to Treatment.  To understand the definition of cellulitis  To know what treatment is appropriate  To know when hospitalization.
MICROBIOLOGICAL EPIDEMIOLOGY OF RESPIRATORY SPECIMENS IN ICU PATIENTS Dr Farooq Cheema, Dr Waseem Tariq, Dr Raja Ishtiaq, Dr Tabassum Qureshi, Dr Vincent.
Methicillin Resistant Staphylococcus Aureus
MRSA Infections on Campus: Focus on Athletes
Methicillin resistant Staphylococcus aureus. There are 2 types of MRSA: Community-acquired MRSA (CA-MRSA) This is passed throughout a community. You hear.
Abscess Management in a Post CA-MRSA era Erin Marra MD Simran Vahali MD 2016.
Staphylococcal Infections Among Injection Drug Users Frederick L. Altice, M.D. Professor of Medicine Yale University School of Medicine.
Outbreak of USA300-like MRSA colonization in a postpartum maternal and neonatal care center in Korea Misuk Ji 1*, Heungsup Sung 1, Ai-rhan Kim 2, Mi-Na.
Staph Infections. What is staph? Staphylococcus aureus, often referred to simply as “staph,” are bacteria commonly carried on the skin or in the nose.
Carriage Rates of Methicillin-Resistant Staphylococcus aureus (MRSA) Among College Students Ryan Kitzinger, Leigh Nelson, Chad Sethman, Ph.D. ABSTRACT.
Molecular epidemiology of MRSA Epidemic and pandemic clones circulation in Romania Professor Lia Monica Junie Professor Lia Monica Junie, University of.
Community-Associated MRSA Infections
Antibiotic Resistance
The Laboratory diagnosis and susceptibility testing of meticilline-resistant staphylococcus aureus By: Maj Anthere Murangwa, MSC Medical Microbiologist.
Diseases caused by Staph. aureus
Clinical Challenges Community Acquired Methicillin Resistant Staph. Aureus Infections Jose R. Jimenez M.D. Eglin AFB, Florida.
Molecular characterisation of
The challenges of multi-drug-resistance in hepatology
Advisor: Dr. Stephanie Booth
Molecular diversity within clonal complex 22 methicillin-resistant Staphylococcus aureus encoding Panton–Valentine leukocidin in England and Wales  E.
Presenter: Zipporah Machuki
Presentation transcript:

Dr. Mona, Chiu Lai Shan, 趙麗珊 Specialist in Dermatology and Venereology Treatment of Skin Bacterial Infections in the Era of Community Associated Methicillin Resistant Staphylococcus Aureus (CA-MRSA) Dr. Mona, Chiu Lai Shan, 趙麗珊 Specialist in Dermatology and Venereology

Lecture outline S. aureus skin infection Epidemiology and clinical characteristics of CA-MRSA Approach to CA-MRSA skin infection

Some facts about S. aureus Colonize the anterior nares in one third of healthy population Colonize the skin of most atopic dermatitis patients (up to 100% in those with severe AD) Common pathogen for skin infection Notorious for secretion of various toxins and superantigens (TSST, enterotoxin) which can cause serious infection and promote inflammation

Skin infections caused by S. aureus Local Cellulitis Abscess Carbuncle Furuncle Impetigo Necrotizing fasciitis systemic Staphylococcus scalded skin syndrome Toxic shock syndrome

When should we suspect that’s CA-MRSA Epidemiology -local prevalence -occupation -hobby -travel history Clinical features Laboratory -antibiotic resistance profile

Background 1981-CA-MRSA outbreak was first described in United States in a group of intravenous drug users 1990s-multiple CA-MRSA outbreaks were documented among different states in the United States 1999-identify as a virulent pathogen after it was identified as the causative organism in the death of four previously healthy children in Minnesota and North Dakota 2004-CA-MRSA was referred as “ an emerging epidemic”

PR Cohen. International Journal of Dermatology 2007. 46:i-11

Mechanism of methicillin resistant in S. aureus Methicillin resistance is mediated by the methicllin resistance gene: mecA gene The gene is responsible for beta-lactam resistance by encoding the methicillin- resistant penicillin binding protein 2a (PBP2a) which has a low affinity for beta-lactam type antibiotics The genetic elements that carries the mecA gene is the staphylococcal cassette chromosome (SCC)

Mechanism of methicllin resistance in S. aureus HA-MRSA infection is associated with SCCmec type I, II, III CA-MRSA infection is associated with SCCmec type IV and V which lacks other multidrug resistance genes CA-MRSA is more frequently associated with exotoxins than the HA-MRSA counterpart Panton-Valentine leukocidin (PVL) toxin is the most common toxin It is lethal to neutophils and is a potent dermonecrotic toxin. It is also associated with necrotizing pneumonitis

HA-MRSA CA-MRSA Patient population Acquired after staying more then 48 hours in the hospital Community without exposure to the hospital environment Pre-disposing factors Surgery, intubation, catheter, dialysis, prior MRSA infection, long term care facility Members of military, IVDU, homosexual males, children, athletes, inmates, Pregnant women, chidren and infants Virulent factors SCCmec type I to III SCCmec type IV or V, Panton-Valentine leukocidin Clinical presentations Systemic infection such as UTI and pneumonia Most common soft tissue and skin infection Antibiotic resistance profile Resistant to most antibiotics except few (e.g.vancomycin, linezolid) Resistant to beta-lactam group of antibiotic but susceptible to quinolones and trimethoprim. Topical fusidic acid and mupirocin. Some are susceptible to clindamycin

Epidemiology-MRSA Large population based survey in the United States showed a 0.84% of overall MRSA colonization rate versus 31.6% of MSSA Worldwide, the overall MRSA colonization rate range from 0.26% to 9.2% The overall prevalence of MRSA is around 1.4% in our locale and most of them are associated with health-care exposure

Epidemiology of MRSA The prevalence is similar in the United Kingdom (1.5%) and <1% in Italy, Portugal and Canada The rate of MRSA colonization is higher in healthy school children in Asian countries: 5.1% in South Korea, 4.3% in Japan, and 1.9% in Taiwan

Epidemiology of MRSA-China There were significant differences in the prevalence of MRSA among distinct regions of China, with the highest prevalence, 76.9%, in east China, 52.3% in the southwest and about 60% in other regions The prevalence of MRSA in certain cities such as Shanghai, Beijing, and Guangzhou was high relative to other 32.7% of S. aureus isolated from pediatric patients was MRSA, which was about half that seen in adult patient

Prevalence of CA-MRSA The incidence of CA-MRSA in children with skin and soft tissue infections was 1.1–4% in Beijing Similar in other major provinces

CA-MRSA in Hong Kong MRSA among patients presenting to the emergency department with purulent SSTI were studied over a 4-month period from November 2006 to February 2007. It involved the emergency departments in six regional hospitals estimated to provide service to half of the 6.6-million inhabitants in Hong Kong Wound swabs were obtained for culture from all patients who present with purulent SSTIs of less than 7 days duration

CA-MRSA in Hong Kong A total of 298 patients aged 2 to 97 with purulent SSTIs were recruited S. aureus was isolated from 126 (42%) patients Among patients with purulent SSTIs, 10% (13/125) of all S aureus isolates was attributed to PVL-positive community- associated MRSA MRSA was isolated from 5% (13/241) of abscesses, 13% (5/40) of infected wounds, and 17% (1/6) of purulent discharges associated with cellulitis

CA-MRSA in Hong Kong In univariate analysis, Filipino ethnicity was significantly more likely than Chinese to be infected by PVL-positive community- associated All other clinical and epidemiologic features were not predictive of PVL- positive community-associated MRSA

Dermatological presentation of CA-MRSA Most common complain “spider bite” lesions Morphology: Papules Pustules Erythematous or crusted erosions Plaques Nodules Distribution Legs Knees Thighs Feet Buttock

Dermatological manifestation Abscess Cellulitis Folliculitis Furunculosis Impetigo Paronychia

Dermatological manifestation Severe infection: Necrotizing fasciitis Bullous erysipelas Staphylococcus scalded skin syndrome and staphylococcus toxic shock syndrome Purpura fulminans Ecthyma gangrenosum

Antibiotic resistance profile of CA-MRSA All are resistance to Beta-lactam group of antibiotics Most are susceptible to ciprofloxacin, rifampacin, cotrimoxazoles, vancomycin, mupirocin and fusidic acid Most are resistance to erythromycin Some are resistance to Clindamycin Resistance to older generation of fluoroquinolones is observed

Antibiotic resistance profile of CA-MRSA-China Resistance rates of 57.1–85.7% to macrolides, clindamycin, aminoglycosides, sulfamethoxazole-trimethroprim, quinolones, and tetracycline Resistance rate to rifampicin was 28.6% Y.-H. Xiao et al. Drug Resistance Updates 14 (2011) 236–250

Antibiotic resistance profile of CA-MRSA in Taiwan Y. -C. Huang, C. -J Antibiotic resistance profile of CA-MRSA in Taiwan Y.-C. Huang, C.-J. Chen / International Journal of Antimicrobial Agents 38 (2011) 2–8

Antibiotic susceptibilities of community-acquiredStaphylococcus aureus isolates recovered from children at Texas Children's Hospital from 1 August 2001 through 31 July 2004. Antibiotic susceptibilities of community-acquiredStaphylococcus aureus isolates recovered from children at Texas Children's Hospital from 1 August 2001 through 31 July 2004. Kaplan S L et al. Clin Infect Dis. 2005;40:1785-1791 © 2005 by the Infectious Diseases Society of America

Antibiotic resistant profile of S. aureus in AD patients in Korea Chung HJ et al. Journal of Clinical Microbiology 2008. 46(3):991-995

When to suspect CA-MRSA infection: Clues for CA-MRSA infection In area of high prevalence Highly susceptible groups Contact history ?more pus and discharge due to presence of PVL toxins Antibiotic susceptibility profile

Basic steps in evaluation and treatment of CA-MRSA Thorough medical history and social history Clinical examination: abscess, cellulitis Risk evaluation: life threatening condition (necrotizing fasciitis) Appropriate culture before empirical antibiotic treatment Drainage of collections Review culture results and clinical response Report any confirmed case and contact tracing Follow up and decontimination

Decolonization of CA-MRSA Decolonization in infected persons is indicated in preventing recurrence and transmission of CA-MRSA Common decolonizing regime: 7.5%/10% povidine iodine soap, 4% chlorhexidine- gluconate liquid detergent, triclosan preparations, mupirocin Active contact tracing and MRSA decolonisation with daily nasal mupirocin and chlorhexidine detergent for showers for 5 days are offered to all carrier is the current regime used in Hong Kong

Conclusions CA-MRSA is an emerging epidemics Skin and soft tissue infection is the most common site of CA-MRSA infection Prompt treatment is needed to prevent bacteremia which can lead to life threatening conditions such as necrotizing pneumonia Incision and drainage is the most effect treatment for abscesses The choice of empirical antibiotics depends on different localities as resistance profiles varies a lot at different countries

Thank you